City of Hope Initiates Liquid Biopsy Study for Early Colorectal Cancer Detection
A new study is underway to develop a non-invasive liquid biopsy assay using cf-circRNAs for early detection of colorectal cancer.
Focal Asset
Hope Initiates
Indication
colorectal cancer diagnostics
Signal Score
8.4
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The initiation of a liquid biopsy study by City of Hope represents a significant advancement in non-invasive cancer diagnostics, particularly for colorectal cancer. This could disrupt existing screening methods and necessitate a reevaluation of current diagnostic portfolios within the industry.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor study progress, results publication, and potential collaborations that may arise from this research.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.